The Nuclear Receptor NR1B1/RARα Arrests the Differentiation of Anti‐Tumor Effector Cytotoxic T Cells
Abstract NR1B1/RARα expression is dynamically regulated in cytotoxic lymphocytes (CTLs) in tumors, but the importance of its expression in anti‐tumor CTLs remains unknown. RARα gene expression is upregulated in CTLs in tumor microenvironments (TME), but its protein expression is downregulated by ret...
Saved in:
| Main Authors: | Patrick Niekamp, Ryun Hee Kim, Adithyan Jayaraman, Nils Klement, Raymond Kostlan, Chang H. Kim |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-05-01
|
| Series: | Advanced Science |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/advs.202410241 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Resistance of breast cancer cells to all-trans retinoic acid is associated with a decrease in the basal level of nuclear receptor <i>RARα</i> expression and induction of cytochrome <i>CYP26A1</i> and <i>CYP26B1</i> expression
by: A. D. Enikeev, et al.
Published: (2022-06-01) -
Design, synthesis, and biological evaluation of novel histone deacetylase 6 selective inhibitors
by: Tianyi Zhang, et al.
Published: (2022-05-01) -
Design and synthesis of thiazole-based hydroxamate histone deacetylase inhibitors with potent antitumor efficacy by inducing apoptosis, pyroptosis and cell cycle arrest
by: Zhijian Li, et al.
Published: (2025-07-01) -
CRISPR activation identifies a novel miR-2861 binding site that facilitates the osteogenesis of human mesenchymal stem cells
by: Seong-Ho Park, et al.
Published: (2024-11-01) -
Recent Advancements in the Development of HDAC/Tubulin Dual-Targeting Inhibitors
by: Christine Tran, et al.
Published: (2025-02-01)